Wataya, Tomohiro http://orcid.org/0000-0002-1224-6601
Miura, Azusa
Sakisuka, Takahisa
Fujiwara, Masahiro http://orcid.org/0000-0003-3423-7658
Tanaka, Hisashi http://orcid.org/0000-0002-6148-0672
Hiraoka, Yu
Sato, Junya http://orcid.org/0000-0002-1206-2036
Tomiyama, Miyuki
Nishigaki, Daiki http://orcid.org/0000-0002-7006-3408
Kita, Kosuke http://orcid.org/0000-0002-5825-3348
Suzuki, Yuki http://orcid.org/0000-0002-1572-5771
Kido, Shoji http://orcid.org/0000-0001-5293-4110
Tomiyama, Noriyuki http://orcid.org/0000-0001-9918-7327
Funding for this research was provided by:
KAKENHI (21H03840)
Article History
Received: 28 November 2023
Accepted: 18 February 2024
First Online: 29 March 2024
Declarations
:
: Yu Hiraoka is the director of GramEye Inc. and owns stock of the company. The other authors declare no conflicts of interest.
: This study was approved by Ethics Review Board of Osaka University Hospital (3/22/2022 #21498). The need for informed consent was waived because of the retrospective nature of this study.